Stock Market & Financial Investment News

News Breaks December 19, 2012 09:00 EDT OSIR Osiris Therapeutics falls 10.4% Osiris Therapeutics is down 10.4%, or $1.05, to $9.01 News For OSIR From The Last 14 Days Check below for free stories on OSIR the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 7, 2013 14:22 EDT OSIR Osiris Therapeutics price target raised to $14 from $11.50 at Piper Jaffray Subscribe for More Information 08:04 EDT OSIR Osiris Therapeutics reports Q1 EPS (8c), consensus (9c) Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.